Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Go back to Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 2.04 -0.01 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.05 | 52 Week High | $0.04 | |||
| Open | $2.00 | 52 Week Low | $0.00 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.00 | EPS | $0.00 | |||
| Volume | 65,306 | |||||
